Sales and Marketing

Showing 15 posts of 11520 posts found.

Sidelined or streamlined? Diabetic care and COVID-19

December 6, 2021 Sales and Marketing

The worldwide restrictions put in place as a result of COVID-19 have necessitated innovation in multiple medical spheres. Diabetes, which …

TIB Molbiol develops test kits for Omicron variant detection

December 6, 2021 Sales and Marketing

TIB Molbiol, a newly acquired subsidiary of Roche, has developed three new VirSNiP test kits for the detection of mutations …

FDA grants Lilly’s COVID-19 antibody therapy EUA for paediatric use

December 6, 2021 Sales and Marketing

Eli Lilly has been granted an expanded Emergency Use Authorisation (EUA) for its neutralising antibody treatment, based on the safety …

J&J COVID-19 booster shows increase in antibody and T-cell responses, in Phase II trial

December 6, 2021 Sales and Marketing

Johnson & Johnson have announced positive results from an independent Phase II study, which reveal that a booster shot of …

Vaccine makers pledge to develop Omicron-effective jab

November 29, 2021 Sales and Marketing

Leading vaccine producers have shared that they are already pursuing vaccine responses to the newly-discovered coronavirus variant, Omicron. BioNTech has …

Nottinghamshire school sets up targeted testing for Omicron

November 29, 2021 Sales and Marketing

A school in Nottingham has set up targeted testing after a case of the new COVID-19 variant, Omicron, was detected …
mufid-majnun-oi20ehignd4-unsplash

WHO: unclear if Omicron causes severe disease

November 29, 2021 Sales and Marketing

WHO has shared that it is still unclear whether the recently-detected coronavirus variant Omicron is more transmissible, or causes more …

FDA approves AI-based breast cancer screening software MammoScreen®

November 29, 2021 Sales and Marketing

The FDA has approved MammoScreen®, Therapixel’s explainable and actionable Artificial Intelligence (AI) based software assisting Radiologists in breast cancer screening. …

FDA approves Pfizer and Moderna boosters for all US adults

November 22, 2021 Sales and Marketing

The FDA and CDC have cleared the Pfizer and Moderna booster jabs for adults, after reviewing new data supporting the …

FDA accept New Drug Application for Obseva’s linzagolix

November 22, 2021 Sales and Marketing

Obseva, a biopharmaceutical company developing and commercialising novel therapies to improve reproductive health, have announced that the NDA for linzagolix …

Novel mechanisms could transform standards of care in multiple cancers, MS, and Lupus

November 22, 2021 Sales and Marketing

Leading science and technology company, Merck KGaA, Darmstadt, Germany have identified five mid- to late-stage assets with first-in-class potential for …

Scientists uncover factors influencing waning immunity with Pfizer COVID-19 vaccine

November 22, 2021 Sales and Marketing

Scientists have discovered multiple factors influencing declining immunity over time with the Pfizer COVID-19 vaccine, according to News Medical.

Emergex trial new form of COVID vaccine

November 15, 2021 Sales and Marketing

Emergex, an Oxfordshire based company, is moving towards Phase I trials for its novel COVID-19 vaccine, which is applied as …
11347696326_bac61dbf66_e

Theramex launches Femarelle to treat menopause symptoms

November 15, 2021 Sales and Marketing

Theramex recently announced that they have acquired the Femarelle ® product licence to treat menopause symptoms. The commercialisation agreement was reached …

Pfizer vaccine generates most antibodies, comparative study suggests

November 15, 2021 Sales and Marketing

Pfizer Inc. and BioNTech’s COVID-19 vaccine yielded the strongest immune response in a comparative study of four vaccines. The study, …
The Gateway to Local Adoption Series

Latest content